Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Measuring the Burden of Comorbidity for Ischaemic Heart Disease and Four Common Non-Communicable Diseases in Iran, 1990-2017: A Modelling Study Based on Global Burden of Diseases Data Publisher Pubmed

Summary: Study shows major depressive disorder with ischemic heart disease has the highest comorbidity burden in Iran over 28 years. #Comorbidity #HeartDisease

Mansourian M1 ; Ghasemi K2 ; Haghdoost A3 ; Kopec JA4 ; Sarrafzadegan N4, 5 ; Islam SMS6
Authors

Source: BMJ Open Published:2022


Abstract

Objective This modelling study aimed to estimate the comorbidity burden for four common non-communicable diseases with ischaemic heart diseases (IHD) in Iran during a period of 28 years. Design Analysis of the burden of comorbidity with IHD based on data included prevalence rates and the disability weight (DW) average for calculating years lived with disability (YLDs) from the Iran population based on the Global Burden of Disease (GBD) study. Setting Population-based available data in GBD 2017 study of Iran population. Participant The source of data was the GBD 2017 Study. We evaluated IHD, major depressive disorder (MDD), diabetes mellitus (DM), ischaemic stroke (IS), and osteoarthritis (OA) age-standardised prevalence rates and their DW. Main outcome measures A new formula that modified the GBD calculator was used to measure the comorbidity YLDs. In the new formula, some multipliers were considered, measuring the departure from independence. Result The contribution of total comorbidity for each combination of IHD with DM, MDD, IS and OA was 2.5%, 2.0%, 1.6% and 2.9%, respectively. The highest YLD rates were observed for IHD_MDD, 16.5 in 1990 and 17.0 in 2017. This was followed by IHD_DM, from 11.5 to 16.9 per 100 000. The YLD rates for IHD_OA changed slightly (6.5-6.7) per 100 000, whereas there was a gradual reduction in the trends of IHD-IS, from 4.0-4.5 per 100 000. Conclusion Of the four comorbidities studied, the highest burden was due to the coexistence of MDD with IHD. Our results highlight the importance of addressing the burden of comorbidities when studying the burden of IHD or any other non-communicable disease. ©
Related Docs
View other Related Docs
1. Burden of Ischemic Heart Diseases in Iran, 1990-2010: Findings From the Global Burden of Disease Study 2010, Journal of Research in Medical Sciences (2015)
2. Burden of Ischemic Heart Disease Attributable to Low Omega-3 Fatty Acids Intake in Iran: Findings From the Global Burden of Disease Study 2010, Journal of Tehran University Heart Center (2016)
3. Trends in Health Burden of Ambient Particulate Matter Pollution in Iran, 1990–2010: Findings From the Global Burden of Disease Study 2010, Environmental Science and Pollution Research (2015)
Experts (# of related papers)
View all Related Experts
Nizal Sarrafzadegan (10)
Masoumeh Sadeghi (6)
Measuring the Burden of Comorbidity for Ischaemic Heart Disease and Four Common Non-Communicable Diseases in Iran, 1990-2017: A Modelling Study Based on Global Burden of Diseases Data
Other Related Docs
4. Estimation of Burden of Ischemic Heart Diseases in Isfahan, Iran, 2014: Using Incompleteness and Misclassification Adjustment Models, Journal of Diabetes and Metabolic Disorders (2017)
5. Burden of Ischemic Heart Disease in Central Asian Countries, 1990–2017, IJC Heart and Vasculature (2021)
6. Metabolic Risk Factors Attributed Burden in Iran at National and Subnational Levels, 1990 to 2019, Frontiers in Public Health (2023)
7. The Burden of Ischemic Heart Disease and the Epidemiologic Transition in the Eastern Mediterranean Region: 1990–2019, PLoS ONE (2023)
8. Healthy and Unhealthy Dietary Patterns Are Related to Depression: A Case-Control Study, Psychiatry Investigation (2015)
9. Burden of Drug and Alcohol Use Disorders in Iran: Findings From the Global Burden of Disease Study 2010, Archives of Iranian Medicine (2015)
10. Body Mass Index, Waist-Circumference and Cardiovascular Disease Risk Factors in Iranian Adults: Isfahan Healthy Heart Program, Journal of Health, Population and Nutrition (2013)
11. Cardiac Rehabilitation Availability and Density Around the Globe, EClinicalMedicine (2019)
12. Isfahan Healthy Heart Programme: A Comprehensive Integrated Community-Based Programme for Cardiovascular Disease Prevention and Control. Design, Methods and Initial Experience, Acta Cardiologica (2003)
13. Avoidable Burden of Cardiovascular Diseases in the Eastern Mediterranean Region: Contribution of Selected Risk Factors for Cardiovascular-Related Deaths, High Blood Pressure and Cardiovascular Prevention (2019)
14. The Impact of Health-Related Quality of Life on the Incidence of Ischaemic Heart Disease and Stroke; a Cohort Study in an Iranian Population, Acta Cardiologica (2016)
15. Burden of Disease Attributable to Vitamin a Deficiency in Iranian Population Aged Less Than Five Years: Findings From the Global Burden of Disease Study 2010, Journal of Diabetes and Metabolic Disorders (2017)
16. The Modifiable Noncommunicable Risk Factors Among an Iranian Population, Southeast Asian Journal of Tropical Medicine and Public Health (2012)
17. Validity of the Iranian Version of Health Utility Index Mark 3 Quality of Life Questionnaire, Journal of Kerman University of Medical Sciences (2017)
18. Determinants of Changes in Metabolic Syndrome Components in a 12-Year Cohort of Iranian Adults, Metabolic Syndrome and Related Disorders (2019)
19. Global, Regional, and National Burden of Stroke and Its Risk Factors, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet Neurology (2024)
20. Dietary Habits and the 10-Year Risk of Overweight and Obesity in Urban Adult Population: A Cohort Study Predicated on Yazd Healthy Heart Project, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2020)